LLY

890.27

+1.4%↑

JNJ

241.35

+0.45%↑

ABBV

211.76

+0.99%↑

NVS

149.7

+0.98%↑

MRK

121.04

+1.14%↑

LLY

890.27

+1.4%↑

JNJ

241.35

+0.45%↑

ABBV

211.76

+0.99%↑

NVS

149.7

+0.98%↑

MRK

121.04

+1.14%↑

LLY

890.27

+1.4%↑

JNJ

241.35

+0.45%↑

ABBV

211.76

+0.99%↑

NVS

149.7

+0.98%↑

MRK

121.04

+1.14%↑

LLY

890.27

+1.4%↑

JNJ

241.35

+0.45%↑

ABBV

211.76

+0.99%↑

NVS

149.7

+0.98%↑

MRK

121.04

+1.14%↑

LLY

890.27

+1.4%↑

JNJ

241.35

+0.45%↑

ABBV

211.76

+0.99%↑

NVS

149.7

+0.98%↑

MRK

121.04

+1.14%↑

Search

Atossa Therapeutics Inc

Closed

4.69 1.74

Overview

Share price change

24h

Current

Min

4.66

Max

4.71

Key metrics

By Trading Economics

Income

-269K

-8.7M

EPS

-0.07

Employees

15

EBITDA

348K

-8.7M

Recommendations

By TipRanks

Recommendations

Strong Buy

12 Months Forecast

+288.35% upside

Market Stats

By TradingEconomics

Market Cap

48M

Previous open

2.95

Previous close

4.69

Technical Score

By Trading Central

Confidence

Bullish Evidence

Atossa Therapeutics Inc Chart

Past performance is not a reliable indicator of future results.

Related News

16 Jan 2026, 23:29 UTC

Hot Stocks

Stocks to Watch: Atossa Therapeutics, Union Pacific

Peer Comparison

Price change

Atossa Therapeutics Inc Forecast

Price Target

By TipRanks

288.35% upside

12 Months Forecast

Average 18.33 USD  288.35%

High 25 USD

Low 10 USD

Based on 3 Wall Street analysts offering 12 month price targets forAtossa Therapeutics Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

3 ratings

3

Buy

0

Hold

0

Sell

Technical Score

By Trading Central

0.7955 / 0.898Support & Resistance

Short Term

Bullish Evidence

Intermediate Term

Strong Bullish Evidence

Long Term

Weak Bearish Evidence

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

help-icon Live chat